Introduction
A pharmaceutical analytical R&D department is responsible for the development and application of test procedures in order to evaluate the stability and quality specifications tbr the drug product and its components. A pharmaceutical analytical R&D department will usually function as a 'QC laboratory' for supplies used during preclinical and clinical investigations. This development stage of the novel drug substance occurs during a six to eight year period for any one project.
These activities culminate in the submission of a regulatory package of intbrmation that supports the commercialization of the product. The environment is dynamic in that project priorities and projects themselves can change on a fairly frequent basis. Only about one in 12 compounds that are recommended for development ever become successful commercial products. Nine of the 12 will never become products because they are clinical tMlures or are economically unpromising. Two of the 12 will be market failures, and only one of the 12 will be a commercial success [1] [6, 7] . However, the [7, 8] . The 
